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Effect of neonatal b3-adrenoceptor agonist CL 316,243 
treatment on body fat accumulation and intestinal  
alkaline phosphatase activity in rats from reduced nests
Zuzana Šefčíková, Ľubomír Raček
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Abstract
Introduction. The aim of this study was to evaluate the effects of early life administration of b3-adrenoceptor 
agonist (CL 316,243) on somatic and feeding parameters, obesity development as well as small intestinal enzyme 
activity in 21- and 40-day-old overfed male Sprague-Dawley rats.
Material and methods. To induce postnatal overnutrition, litter size was reduced to 4 pups/litter (small litters, 
SL); while in normally-nourished groups (NL) the litter size was adjusted to 10 pups/litter. From days 5 to 15, 
half of the suckling pups from NL and SL groups received CL 316,243 subcutaneously. From 21st to 40th day, in 
the post-weaning period, both control (NL, SL) and CL 316,243-treated (NL-CL, SL-CL) rats had free access 
to standard diet and water. Body composition was determined by magnetic resonance imaging, blood pressure 
was measured using non-invasive tail-cuff, and intestinal alkaline phosphatase (AP) activity was assessed by 
histochemistry.
Results. At 21 and 40 days of age the SL rats showed higher body mass, displayed higher adiposity and had 
significantly increased duodenal and jejunal AP activity compared with NL animals. On day 21, NL and SL rats 
treated with CL 316,243 showed significantly less fat deposition and jejunal AP activity than the non-treated 
controls. In contrast, treatment-related changes in adiposity and AP activity were not observed in 40-day-old 
NL-CL, SL-CL rats. 
Conclusions. These results indicate that early pharmacological intervention with CL did not permanently in-
fluence physiological processes involved in body weight/fat regulation, which resulted in the development of 
early-programmed overweight status in SL rats after weaning. (Folia Histochemica et Cytobiologica 2015, Vol. 53, 
No. 4, 307–313)
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Introduction
In general, obesity develops when energy intake 
chronically exceeds energy expenditure, resulting 
in storage of excess energy in white adipose tissue 
(WAT). It has been documented that the critical 
factor influencing physiological processes involved 
in food intake, body weight regulation and adiposity 
control throughout life is nutritional status in the 
early developmental phase [1, 2]. For example, over-
feeding due to higher maternal milk fat content and 
increased milk availability in rats from reduced litters 
(3–4 pups/litter) resulted during later life in enhanced 
weight gain, increased body fat stores and a complex 
of obesity-related alterations, particularly increased 
plasma insulin, leptin and glucose [3–5]. Moreover, 
available data suggest that exposure of rat pups to 
high-fat milk during this critical period of life leads 
also to alterations in small intestine functionality [2]. 
These changes include early postnatal adjustment 
of intestinal enzymes’ activity, which participate in 
energy-balance control in later life and may be con-
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sidered as one of the factors causing obesity. Alkaline 
phosphatase (AP) is present mainly in the microvilli 
of small intestine enterocytes, where it is involved in 
nutrient (fat) absorption. Its activity displays circa dian 
fluctuations, i.e. it is dependent on actual feeding con-
ditions [6], becomes significantly decreased after food 
deprivation [7], and also increases markedly after fat-
-rich diet feeding [8–11]. Furthermore, some studies 
have revealed in rat pups subjected to pre-weaning 
overnutrition via litter size reduction significantly 
higher AP activity in the small intestine in comparison 
with rats nursed in normal nests on days 15 and 20, as 
well as on days 40, 50 and 80 [2, 12–14]. 
Other animal studies showed that the early nu-
tritional imprint in small litter (SL) rats also causes 
morphological and functional changes in interscapular 
brown adipose tissue (BAT) in the juvenile and/or 
adult phase of life, leading to reduced BAT thermo-
genesis and energy expenditure in SL rats, which also 
probably increases susceptibility to obesity [1, 15, 16]. 
Lipolysis in WAT and thermogenesis in BAT is 
controlled via sympathetic nervous system. Direct 
visual evidence that WAT is indeed innervated by 
the sympathetic neurons that establish neuro-adipose 
junctions, directly ‘enveloping’ adipocytes, has been 
recently published [17]. The results of this study sug-
gest also that the direct activation of the sympathetic 
nervous inputs to adipose tissue may represent strategy 
for fat mass reduction.
In rodents, b3-adrenergic receptors are predomi-
nantly present in BAT and WAT, where their stim-
ulation by selective b-adrenergic agonists results in 
increased energy expenditure in BAT and elevated 
lipid mobilization in WAT. It was shown that long-
-term administration of CL 316,243 (CL), a highly 
selective b3-adrenoceptor agonist, largely reduced 
fat stores and retarded the development of obesity in 
young rats fed a high-fat diet [18], as well as reversed 
established diet-induced obesity in older animals 
[19–21]. Similar fat-reducing effect of CL was also 
described in adult non-obese rats [22, 23].
At present, however, there is a lack of information 
about the impact of neonatal b3-adrenergic agonist 
treatment (increasing energy expenditure and lipoly-
sis) on the later occurrence and/or attenuation of 
obesity and related health complications (increased 
food intake, blood pressure and AP activity) in rat 
pups nursed either in reduced or in normal litters. 
Using litter-size adjustment as an experimental design 
allowed us to evaluate whether early-life CL 316,243 
intervention could counteract accumulation of body 
fat and reverse early programming of obesity in rat 
offspring after weaning. The purpose of this study was, 
therefore, to determine the differences in body growth 
parameters as well as brush border-bound duodenal 
and jejunal alkaline phosphatase activity in 21- and 40- 
-day-old postnatally overfed (4 pups/nest) and normally 
fed (10 pups/nest) CL 316,243 treated rats, as well as 
in their saline-treated control littermates submitted to 
the same postnatal nutritional manipulations.
Material and methods
Animals. All animal experiments were reviewed and ap-
proved by the Ethical Committee for animal experimenta-
tion of the Institute of Animal Physiology, approved by the 
State Veterinary and Food Administration of the Slovak 
Republic, and were performed in accordance with Slovak 
legislation (Law No. 377/2012) on the protection of animals 
used for experimental and other scientific purposes.
Sprague-Dawley virgin rat dams (Charles River Labora-
tories, Prague, Czech Republic) weighing 240–260 g, mated 
at 10 weeks of age, were individually housed in Plexiglas cages 
and kept under conditions of constant room temperature 
(22 ± 2°C), relative humidity (55 ± 10%) and 12 h light/dark 
cycle (light on 06:00 to 18:00 h) with free access to a standard 
laboratory diet (containing 13.4 kJ/g, with 26.3% energy as 
protein, 9.5% as fat and 64.2% as carbohydrate; Laboratory 
diet M1, Řicmanice, Czech Republic) and tap water. Within 
24 h of parturition, the litters with less than 8 or more than 
12 pups were excluded from the experiment. To induce early 
postnatal normal nutrition or overnutrition, the litter size in 
one group of dams (n = 5) was adjusted after parturition to 
10 pups per nest (normal litters, NL) and in the other group 
of dams (n = 11) to 4 pups per nests (small litters, SL). Half 
of the number of pups in each nest (CL groups) was injected 
subcutaneously with b3-adrenoreceptor selective agonist, 
CL 316,243 (5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydro-
xyethyl]amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate, 
Sigma-Aldrich, Deisenhofen, Germany) at a dose of 1 mg/kg 
of body weight per day, or an equivalent volume of saline 
solution (control groups), daily from day 5 to 15 after birth. 
After weaning (on day 21), the male rats were individually 
housed under the standard laboratory conditions (water, 
temperature, light-dark regime) with free access to a stand-
ard laboratory diet up to day 40.
To determine the growth and post-weaning feeding per-
formance in all four mentioned groups, the body weight was 
measured at birth and then every 5 days, and from day 21 to 
40 their food intake was recorded every 48 hours. On days 
21 and 40, duodenal and jejunal segments were taken for 
enzyme assay after decapitation of the animals (between 08:00 
and 09:00 h). Bilateral epididymal and perirenal WAT as well 
as interscapular BAT samples were removed and weighed.
Determination of milk composition. The individual dams 
were milked on day 10 of lactation. Two hours before milking 
the dams were separated from their pups, which were kept 
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in a constant temperature chamber 34 ± 1°C, and 10 min 
before milking the dams received 2 IU oxytocin (Sigma- 
-Aldrich) intraperitoneally. Milk fat was measured using the 
crematocrit method of Lucas et al. [24] and its concentration 
was expressed in g/100 mL milk using the formula given by 
Nagasawa et al. [25].
Measurement of alkaline phosphatase activity. For enzyme 
assay, small (0.5 cm) segments of the duodenum and middle 
part of the jejunum were immediately removed; the lumen was 
rinsed in distilled water and samples were frozen in liquid ni-
trogen. Segments of frozen tissue were cut (8 μm) in a cryostat 
at –25°C, and the tissue slices were transferred to glass slides 
and air-dried. The analysis of alkaline phosphatase activity 
was performed using a modified simultaneous azocoupling 
method [26]. The incubation medium contained 2.0 mmol/L 
naphthol AS-BI phosphate (Sigma-Aldrich), 0.8 mmol/L hex-
azotized new fuchsin (Serva, Heidelberg, Germany), and 0.05 
mol/L veronal acetate buffer. The sections were incubated at 
37°C for 10 min at pH 8.9 [27].
The histochemically-stained slides were illuminated with 
white light after filtering with a 520 nm monochromatic filter 
and visualized with image analysis tool (Ellipse program 
ViDiTo, Košice, Slovakia), where the gray level of each pixel 
was given a value in the range 0–255. The correspondence 
between the gray level values and the known integrated ab-
sorbance values of the same section points was determined 
by calibration. A special semi-interactive algorithm was used 
to find relevant pixels along the villus length, which density 
was measured [28]. Quantification of the enzyme activity 
(pixel intensities) was carried out along the villus length in 
a whole section of at least four samples, and the mean values 
recorded were referred to one animal [29].
Fat mass measurements. Body composition was deter-
mined using magnetic resonance imaging (Echo MRI-700 
TM, Echo Medical Systems, Houston, TX, USA). Scans of 
male rats were performed from day 10 to 40 with the Whole 
Body Analysis protocol in the scanner software package at 
10-day intervals. Body composition data were reported as 
absolute mass of fat in grams. The percentage of body fat 
was calculated from the body weight in grams.
Blood pressure measurements. Blood pressure was non-in-
vasively measured by determining the tail blood volume 
using a volume pressure recording sensor and occlusion tail-
cuff method (CODA System, Kent Scientific, Torrington, 
CT, USA). Before recording, the rats were adapted to the 
measurement conditions for at least 10–15 min over a period 
of 3 days. For each animal, the mean systolic and diastolic 
values were calculated from 10 measurements on day 40.
Statistical analysis. Statistical analyses were performed 
using the Statistica AXAZ software package (StatSoft CR, 
Prague, Czech Republic). Two-way ANOVA followed by 
Fisher’s LSD hoc test were used for detecting significant 
differences between SL and NL groups and for evaluating 
their responses to the CL 316,243 treatment. Data were sum-
marized as means ± SEM. A p < 0.05 level was considered 
statistically significant.
Results
Milk composition
Reduction of litter size resulted in a significant in-
crease in milk fat concentration on day 10 postpartum. 
In SL nursing dams as compared with NL mothers the 
mean values of milk fat concentration were 17.56 ± 
± 0.8 vs. 13.0 ± 0.05 g/100 mL, respectively (p < 0.001).
Effects of litter size manipulation
There was no significant difference in the average 
body weight between NL pups (10 pups/dam) and SL 
(4 pups/dam) on postnatal day 1 (6.5 ± 0.06 vs. 6.5 ± 
± 0.11, respectively). The male pups from SL litters 
compared with the NL controls showed significantly 
higher final body weight and weight gain, as well as 
significantly higher accretion of epididymal plus peri-
renal fat pads weight expressed as the percentage of 
body weight on day 21 and on day 40 (Table 1). 
These somatic differences persisted in SL rats 
despite post-weaning access to identical diets as con-
sumed by the controls. In addition, the data from mag-
netic resonance imaging (Echo MRI-700 TM) demon-
strated in SL rats relative body fat mass (% b.w.) 
significantly exceeding the values for NL rats by 48% 
on day 10, 70% on day 20 and 19% on day 40 (Figure 1). 
During the post-weaning period (from day 21 to 40), 
in SL rats significantly higher food intake by 8.93% 
was recorded than in NL controls (Table 1). 
The effect of overfeeding induced by small litter 
rearing resulted in different functional maturation 
of the small intestine; in particular, significantly 
increased (p < 0.01) duodenal and jejunal alkaline 
phosphatase activity was recorded on days 21 and 
40 (Table 1, Figure 2). Moreover, SL rats compared 
with the NL controls had significantly increased 
systolic (149.30 ± 5.83 vs. 128.80 ± 2.70 mm Hg, 
respectively) and diastolic (110.50 ± 5.31 vs. 95.50 ± 
± 3.83 mm Hg, respectively) blood pressure.
Effect of b3-adrenoceptor agonist — CL 316,243 
treatment
We found that 10 days of repeated CL 316,243 
administration did not influence final body weight 
and weight gain on postnatal day 21 (Table 1). 
Even though the control and the CL-treated rats 
had identical final body weight at sacrifice, the 
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adiposity determined by whole-body MRI scans was 
significantly, and to a similar extent, reduced in both 
groups treated with CL: on day 20 the body fat mass 
was reduced by 20% and 19% in NL-CL and SL-CL 
rats, respectively, as compared to non-treated NL 
and SL animals (Figure 1B). Moreover, exposure 
of NL and SL rats to CL treatment led on day 21 to 
a significant reduction of epididymal and perirenal 
fat pads expressed as the percentage of body weight 
(NL-CL 53% vs. SL-CL 26%) as compared to NL and 
SL controls. The interscapular brown adipose tissue 
expressed as the percentage of body weight was not 
affected by CL administration in normal litter reared 
pups (0.47 ± 0.01 for NL vs. 0.44 ± 0.02 for NL-CL) 
as well as in small litter reared pups (0.62 ± 0.03 for 
SL vs. 0.58 ± 0.02 for SL-CL).
The administration of b3-adrenoceptor agonist 
significantly decreased intestinal alkaline phosphatase 
activity in 21 day-old rats both in NL-CL and SL-CL 
animals (Table 1). 
However, this processed did not persist for longer 
time, since on day 40, at the end of the experiment; 
rats treated with CL 316,243 displayed a non-signifi-
cant tendency toward body fat reduction and intestinal 
functional changes (Table 1). 
There were no apparent differences in food intake 
between both NL and SL rats treated with the CL 
316,243 and their respective controls. Furthermore, in 
both CL 316,243-treated groups, we did not observe 
differences in systolic and diastolic blood pressure 
parameters compared with the NL and SL controls 
on day 40 (data not shown).
Discussion
It is generally known that nutritional changes during 
the critical initial period of life contribute to the de-
velopment of various diseases in adulthood, including 
obesity and obesity-related health complications. 
The findings of the present study show that early life 
overfeeding due to higher milk fat content in SL rats 
resulted in an accelerated overall growth persisting 
throughout experiment despite transition to standard 
laboratory feeding conditions after weaning. Similarly, 
data from magnetic resonance imaging and our mon-
itoring of epididymal plus perirenal fat pad mass at 
the end of the experiment revealed significantly higher 
fat mass in rats from small litters than from normal 
litters. Moreover, our data also indicate that altered 
nutritional background during the pre-weaning 
period significantly increased duodenal and jejunal 
brush-border-bound alkaline phosphatase activity 
in 21- and 40-day-old small litter rats in comparison 
with NL rats. It can be assumed that these acquired 
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intestinal changes represent significant determinants 
for future physiological processes regulating metabo-
lism and body composition. Alkaline phosphatase is 
a crucial brush-border enzyme functionally involved in 
nutrient (fat) absorption in the intestinal mucosa [30]. 
For this reason the diet can be considered as a major 
factor influencing AP activity. It has been previously 
documented that elevated alkaline phosphatase ac-
tivity occurs in rats [8, 12] and mice [31] in response 
to increased fat content in the diet. Current data also 
suggest that the rat’s intestine adapts to a high-fat 
diet differentially depending on early nutrition. This 
is supported by the finding that whereas in adulthood 
jejunal alkaline phosphatase activity doubled in re-
sponse to high-fat diet feeding in control rats, this 
effect was not recorded in perinatally malnourished 
rats [11]. Recently, it has been revealed that inactiva-
tion of the AP gene (Akp3) resulted in faster weight 
gain and fat accumulation in mice fed a high-fat diet 
in comparison with wild-type controls, suggesting 
Figure 1. Whole body fat mass (% b.w.) on day 10 (A), on 
day 20 (B) and on day 40 (C) in normal litter (NL), small 
litter (SL) and CL 316,243-treated rats NL-CL, SL-CL was 
determined using magnetic resonance imaging. Values are 
means ± SEM (18 animals/group on days 10 and 20; 10 ani- 
mals/group on day 40). Significant differences between 
NL vs. SL groups (***p < 0.001), between NL vs. NL-CL 
(###p < 0.001), between SL vs. SL-CL groups (†††p < 0.001), 
between NL-CL vs. SL-CL ($p < 0.05, $$$p < 0.001) based 
on Fisher’s LSD comparison test after two-way ANOVA
Figure 2. Histochemical demonstration of jejunal alkaline 
phosphatase activity in cryosections of 40-day-old NL and SL 
rats. The enzyme activity is expressed in the brush-border of 
absorption cells of the intestinal villi in NL (A) and SL (B) rats
A
B
C
A
B
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that AP may negatively regulate fat absorption [31]. 
Nevertheless, this phenomenon probably resulted 
from the concomitant up-regulation of Akp6 gene in 
distal regions of the intestine involved in accelerated 
fat absorption in these mice [32].
Moreover, changes in early postnatal diet mod-
ified not only the somatic and enzymatic/functional 
status of our rats, but also their blood pressure, i.e. in 
over-nourished SL rats significantly elevated systolic/ 
/diastolic blood pressure was found in comparison with 
NL rats, even when they were subjected to consump-
tion of standard laboratory diet after weaning.
Since the prevalence of obesity worldwide contin-
ues to increase, and the current strategies involved in 
the prevention and treatment of obesity have been 
minimally effective, interest in novel therapeutic inter-
ventions has burgeoned. It was previously suggested 
that b3-adrenoceptor, the predominant subtype of 
adrenoceptor expressed mainly in white and brown 
adipose tissue play an important role in the regulation 
of lipolysis, thermogenesis and energy homeostasis. 
Earlier studies reported that b3-adrenergic receptor 
stimulation in rats and mice fed high-fat diets is very 
effective in normalization of obesity [20, 21]. More-
over, 4 weeks treatment of obese Zucker rats with 
CL 316,243 resulted in an increase metabolic rate by 
96% per rat as well as in decrease and remodeling 
of retroperitoneal white fat depots [33]. In contrast, 
mice lacking b3-adrenergic receptor had modestly 
increased fat stores [34].
The aim of this study was therefore to determine 
whether early-life b3-adrenergic agonist administra-
tion leads to prevention and/or attenuation of obesity 
development in male rats subjected to nutritional 
manipulation during the suckling period. To this 
end we examined the effects of different nutritional 
conditions via litter size reduction and 10 days of treat-
ment with selective b3-adrenergic agonist CL 316,243 
on adjustment of the future energy balance control 
and body fat regulation in NL-CL and SL-CL groups 
compared to the non-treated controls. Our results 
confirm the fat-reducing effect of the b3-adrenergic 
agonist CL in 21 day old pre-weaning SL rats. These 
rats showed apparent reduction of whole body fat 
as well as epididymal and perirenal fat pads despite 
their higher dietary energy intake due to significantly 
higher milk fat concentration. Moreover, these fat-re-
ducing changes were accompanied with significantly 
decreased brush border-bound AP activity of jejunal 
enterocytes in the SL-CL-treated group as compared 
to SL rats. In this regard, it seemed that the reduction 
in intestinal AP activity recorded in the CL-treated 
groups on day 21 could have considerable effect on 
energy balance control and might perhaps contribute 
to obesity prevention. 
On the other hand, our results indicate that this 
anti-obesity impact of early-life CL treatment disap-
peared in 40 day old SL rats, i.e. in SL-CL rats similarly 
sustained elevations in adipose depots and increased 
intestinal parameters of enzyme activity were found 
as in their overfed but non-treated littermates. Ac-
cording to our results this lack of long-term impact of 
b3-agonist on energy balance control and body weight/ 
/fat regulation in rats with different nutritional back-
ground (excess fat intake) during the critical period 
led to the development of similar overweight status as 
in the case of non-treated SL rats. CL treatment was 
not essential for apparent reduction of body fat re-
serves, and previously acquired somatic and functional 
differences continued until the end of the experiment.
Conclusions
The results of our study indicate that early-life 
b3-adrenoceptor agonist CL 316,243 administration 
did not permanently protect against development 
of adiposity in rat pups subjected to obesogenic diet 
(high fat milk) during the suckling period. Moreover, 
adjustment of the intestinal-bound AP activity to 
a lower level in pre-weaning SL rats was only tran-
sitory and withdrawal of previous pharmacological 
intervention (CL 316,243 treatment) resulted in 
similarly increased post-weaning intestinal alkaline 
phosphatase activity and body fat accretion as found 
in control rats. Therefore, additional information 
focused on developmental and enzymatic adaptability 
in rats under different nutritional conditions will be 
needed for better understanding of the mechanisms 
involved in body fat regulation and adiposity control. 
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